Legal & General Group
DOVA

Legal & General Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Legal & General Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,269
Closed -$35K – 3402
2019
Q3 		$35K Sell
1,269
-483
-28% -$7.83K ﹤0.01% 2898
2019
Q2 		$25K Hold
1,752
– – ﹤0.01% 3118
2019
Q1 		$16K Hold
1,752
– – ﹤0.01% 3162
2018
Q4 		$13K Hold
1,752
– – ﹤0.01% 3223
2018
Q3 		$37K Hold
1,752
– – ﹤0.01% 2932
2018
Q2 		$52K Buy
1,752
+802
+84% +$21.8K ﹤0.01% 2731
2018
Q1 		$26K Hold
950
– – ﹤0.01% 3045
2017
Q4 		$27K Buy
950
+300
+46% +$8.22K ﹤0.01% 3097
2017
Q3 		$16K Buy
+650
New +$15.4K ﹤0.01% 3224

Legal & General Group's DOVA Position: Q4 2019 in Review

Legal & General Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 1,269 shares — an estimated $35K sold.

Legal & General Group first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $52K in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Legal & General Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Legal & General Group sold 1,269 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $35K.
  • Legal & General Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Legal & General Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $52K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.